20 Results

People

  1. Wolchok
    Wolchok
  2. Friedman
    Friedman
  3. Funt
    Funt
  4. Page
    Page
  5. Postow
    Postow
  6. Riaz
    Riaz
  7. Yuan
    Yuan
  8. Zamarin
    Zamarin
  9. Zappasodi
    Zappasodi
  10. Adams
    Adams

Groups

  1. Department of Medicine (10)
  2. GSK Faculty (9)
  3. Solid Tumor Oncology Division (7)
  4. Sloan Kettering Institute Postdocs (6)
  5. Center for Hematologic Malignancies (5)
  6. Melanoma and Immunotherapeutics Service (5)
  7. GDMT, Medicine (4)
  8. Gynecologic Medicine Service (4)
  9. Gynecology Disease Management Team (4)
  10. Hematologic Malignancies, Division of (4)
  1. "regulatory t-cells"
Formats
  1. Journal Article (17)
  2. Review (2)
  3. Book Section (1)
Groups
  1. Department of Medicine (10)
  2. GSK Faculty (9)
  3. Solid Tumor Oncology Division (7)
  4. Sloan Kettering Institute Postdocs (6)
  5. Center for Hematologic Malignancies (5)
  6. Melanoma and Immunotherapeutics Service (5)

More Groups

People
  1. Jedd Wolchok (4)
  2. Claire Friedman (2)
  3. David Page (2)
  4. Dmitriy Zamarin (2)
  5. Jianda Yuan (2)
  6. Michael Postow (2)

More People

Years
  1. 2022 (2)
  2. 2021 (1)
  3. 2020 (2)
  4. 2018 (1)
  5. 2017 (4)
  6. 2016 (5)

More Years

Publications
  1. Clinical Cancer Research (2)
  2. Journal for ImmunoTherapy of Cancer (2)
  3. Nature Immunology (2)
  4. Advances in Immunology (1)
  5. Annals of Oncology (1)
  6. Blood and Lymphatic Cancer: Targets and Therapy (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. Nature Publishing Group (4)
  3. Biomed Central Ltd (2)
  4. Amer Assoc Advancement Science (1)
  5. Amer Soc Clinical Investigation Inc (1)
  6. C M P Medica LLC * The Oncology Group (1)

More Publishers

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CXCR4(+) Treg cells control serum IgM levels and natural IgM autoantibody production by B-1 cells in the bone marrow
    Journal Article

    Elias, S.; Sharma, R.; Schizas, M.; Valdez, I.; Rampersaud, S.; Park, S. M.; Gonzalez-Figueroa, P.; Li, Q. Z.; Hoyos, B.; Rudensky, A. Y.
    Journal of Experimental Medicine (2022)

    Fulltext@MSK | Save
  • A decade of checkpoint blockade immunotherapy in melanoma: Understanding the molecular basis for immune sensitivity and resistance
    Review

    Huang, A. C.; Zappasodi, R.
    Nature Immunology (2022)

    Fulltext@MSK | Save
  • Tumor immunity and immunotherapy for HPV-related cancers
    Review

    Shamseddine, A. A.; Burman, B.; Lee, N. Y.; Zamarin, D.; Riaz, N.
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Immunotherapy and gliomas
    Book Section

    Wang, E.; Young, R. J.; Bhatia, A.
    In Pope, W. B. (Eds.) Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches (2020)

    Fulltext@MSK | Save
  • Mogamulizumab in combination with durvalumab or tremelimumab in patients with advanced solid tumors: A phase I study
    Journal Article

    Zamarin, D.; Hamid, O.; Nayak-Kapoor, A.; Sahebjam, S.; Sznol, M.; Collaku, A.; Fox, F. E.; Marshall, M. A.; Hong, D. S.
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy
    Journal Article

    Marciscano, A. E.; Ghasemzadeh, A.; Nirschl, T. R.; Theodros, D.; Kochel, C. M.; Francica, B. J.; Muroyama, Y.; Anders, R. A.; Sharabi, A. B.; Velarde, E.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Core-binding factor β and Runx transcription factors promote adaptive natural killer cell responses
    Journal Article

    Rapp, M.; Lau, C. M.; Adams, N. M.; Weizman, O. E.; O'Sullivan, T. E.; Geary, C. D.; Sun, J. C.
    Science Immunology (2017)

    Fulltext@MSK | Save
  • Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies
    Journal Article

    Karantanos, T.; Politikos, I.; Boussiotis, V. A.
    Blood and Lymphatic Cancer: Targets and Therapy (2017)

    Fulltext@MSK | Save
  • Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma
    Journal Article

    Gopal, A. K.; Fanale, M. A.; Moskowitz, C. H.; Shustov, A. R.; Mitra, S.; Ye, W.; Younes, A.; Moskowitz, A. J.
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Interleukin-33-induced expression of PIBF1 by decidual B cells protects against preterm labor
    Journal Article

    Huang, B. H.; Faucette, A. N.; Pawlitz, M. D.; Pei, B.; Goyert, J. W.; Zhou, J. Z.; El-Hage, N. G.; Deng, J.; Lin, J.; Yao, F. Y.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save